The Technical Analyst
OrganiGram Holdings Inc [OGI]
Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
OrganiGram Holdings Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
0.81% $1.875
America/New_York / 26 apr 2024 @ 14:21
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 176.43 mill |
| EPS: | -1.840 |
| P/E: | -1.020 |
| Earnings Date: | Apr 30, 2024 |
| SharesOutstanding: | 94.10 mill |
| Avg Daily Volume: | 1.456 mill |
| RATING 2024-04-26 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Sell | |
| P/E: | Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.020 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.02x |
| Company: PE -1.020 | industry: PE 47.78 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.666 - 2.08 ( +/- 11.15%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
Forecast
1: 14:33 - $1.871
Forecast 2: 15:23 - $1.877
Forecast 3: 16:00 - $1.870
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.875 (0.81% ) |
| Volume | 0.591 mill |
| Avg. Vol. | 1.456 mill |
| % of Avg. Vol | 40.63 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For OGI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $2.20 | N/A | Active |
|---|
OGI
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Latest Press Releases
2024-04-03 08:06:00 - Press Release
Organigram's Popular Shred Brand Surpasses $200 Million In Yearly Retail Sales
Toronto--(business wire)--organigram holdings inc. (nasdaq: ogi) (tsx: ogi), (the “company” or “organigram”), a leading licensed producer of cannabis, celebrates a monumental achievement as its shred brand surpasses the $200 million mark in yearly retail sales.1 shred revolutionized the cannabis industry in september 2020 when it launched as the first brand to offer high-quality, convenient, milled flower in three bold flavour territories, produced using only high-quality whole flower. by being.
2024-04-02 08:52:00 - Press Release
Everything Golden For Nexsan On Eve Of Silver Anniversary
Sunnyvale, calif.--(business wire)--nexsan®, the pioneer of highly reliable, cost-effective enterprise-class storage solutions, is celebrating 25 years of delivering storage solutions enterprises trust for their most critical data needs, backed by the innovation and reliability that has made the company a trusted leader in the industry. founded in 1999, nexsan has consistently delivered high-performance and scalable storage technologies tailored to meet global organizations' complex and evolvin.
2024-04-02 08:51:00 - Press Release
Organigram Successfully Closes Previously Announced Underwritten Public Offering
Toronto--(business wire)--organigram holdings inc. (“organigram” or the “company”) (tsx: ogi; nasdaq: ogi) announces today the closing of its previously announced underwritten public offering of units of the company (the “units”) for total gross proceeds of c$28,750,230 (the “offering”). the company sold 8,901,000 units at a price of c$3.23 per unit, which included 1,161,000 units sold pursuant to the exercise in full of the underwriters' over-allotment option. each unit is comprised of one com.
2024-03-27 08:56:00 - Press Release
Organigram Announces Pricing Of Overnight Marketed Public Offering
Toronto--(business wire)--organigram holdings inc. (“organigram” or the “company”) (tsx: ogi; nasdaq: ogi), announces today that, in connection with its previously announced overnight marketed public offering of units of the company (the “units”), it has entered into an underwriting agreement with atb securities inc., as lead underwriter, on behalf of itself and a syndicate of underwriters to sell 7,740,000 units at a price of c$3.23 per unit (the “offering price”) for total gross proceeds of a.
2024-03-26 19:06:00 - Press Release
Organigram Announces Launch Of Overnight Marketed Public Offering
Toronto--(business wire)--organigram holdings inc. (“organigram” or the “company”) (tsx: ogi; nasdaq: ogi), announces today an overnight marketed public offering of units of the company (the “units”) for total gross proceeds of approximately c$25 million (the “offering”). the offering is expected to be completed pursuant to an underwriting agreement to be entered into between the company and atb securities inc., as lead underwriter, on behalf of itself and a syndicate of underwriters including.
Latest News
2024-04-26 10:46:03 - Zacks Investment Research
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
Here is how OrganiGram (OGI) and ResMed (RMD) have performed compared to their sector so far this year.
2024-04-21 13:02:41 - Seeking Alpha
Organigram Is My Favorite Cannabis Stock Again
Organigram stock has performed well this year, despite an equity raise and a temporary pullback caused by Tilray's poor financial report. The fiscal Q1 report showed a revenue shortfall, particularly in international sales, but positive operating cash flow. Analysts' outlook for Organigram's future revenue and adjusted EBITDA has remained relatively stable.
2024-03-28 09:56:09 - Zacks Investment Research
Why OrganiGram (OGI) Might Surprise This Earnings Season
OrganiGram (OGI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
2024-03-24 09:40:06 - MarijuanaStocks
The Marijuana Stocks Could See A Rise This Week
People who have been investing in marijuana stocks could soon a big change. Now this change is more from an industry standpoint which can in turn help how marijuana stocks trade. As most publicly traded companies news about the sector or individual company can impact trading. Marijuana stocks are no different in fact they can have a greater impact due to how volatile the sector can be. Nonetheless, it is yet to stop others from looking for the best marijuana stocks to buy.
2024-03-21 16:05:01 - InvestorPlace
Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5
You get what you pay for and that includes stocks under $5. Yeah, I might be starting off on a negative foot but here's the deal: most securities that are priced this low are that way for a reason.
2024-03-06 09:06:59 - MarijuanaStocks
Top Marijuana Stocks For Trading Today 2024
More publicly traded cannabis companies are starting to report earnings. This alone has been another reason shareholders have seen a slight increase in trading momentum for marijuana stocks. Speculation is high in 2024 for those who are invested in legal cannabis. Political figures from all parties are starting to find common ground with the cannabis industry.
2024-03-02 11:00:03 - MarijuanaStocks
2 Top Marijuana Penny Stocks with High Momentum Before March 2024
As March 2024 begins, marijuana stocks are catching the eyes of investors looking for potential growth opportunities. The cannabis industry in the U.S. has seen rapid expansion and evolution, driven by increasing legalization and public acceptance. Several marijuana companies, operating at lower stock prices, offer intriguing entry points for speculative investment. These companies range from growers and retailers to technology firms offering innovative cultivation, distribution, and consumer experience solutions. With the dynamic landscape of the cannabis sector, these penny stocks represent both the volatility and potential rewards that come with early-stage investment in a growing industry.
2024-02-27 15:46:02 - Proactive Investors
Organigram and Aurora Cannabis increasingly attractive as Canopy Growth's core operations struggle: analysts
Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) are increasingly attractive on the back of encouraging quarterly financial results, analysts at Jefferies believe. They have a ‘Buy' rating on Organigram, which they said remains a top Canadian cannabis pick, writing in a note to clients that Organigram's first quarter 2024 earnings showed progress on every metric.
2024-02-20 13:27:58 - InvestorPlace
3 Millionaire-Maker Cannabis Penny Stocks to Buy in February 2024
Support for the legalization of cannabis is at an all-time high. In fact, according to a recent Gallup poll, about 70% of all Americans support legalization.
2024-02-10 18:25:10 - MarijuanaStocks
Leading Canadian Cannabis Stock Powers Through with Strong Weekly Momentum
In February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for investors. Market movements were influenced by quarterly earnings reports, with some companies exceeding expectations and others falling short. This period saw significant attention to operational efficiencies and international expansion efforts. Additionally, updates on product innovation and strategic partnerships were crucial. Investors closely monitored these developments, leveraging technical analysis to identify potential entry and exit points.